Search Medical Condition
Please enter condition
Please choose location from dropdown

Skin Infections/Disorders Clinical Trials

A listing of Skin Infections/Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (29) clinical trials

Volunteers with neutrophilic skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women diagnosed with one ...

Phase

The purpose of this study is to test the safety, tolerability and efficacy of the drug, iclaprim. It will be compared to vancomycin for the treatment of bacterial skin infections caused by bacteria called Gram-positive bacteria. Both these drugs are antibiotics (drugs that kill bacteria). Iclaprim is an experimental drug, ...

Phase N/A

Please consider this clinical research study your colleagues are conducting. A clinical research study for skin and skin structure infections is enrolling now. This study is a double-blind, multicenter, randomized, Phase 3 study comparing an investigational antibiotic versus linezolid for the treatment of adults with ABSSSI. This study is enrolling ...

Phase N/A

This is a double-blind, randomized, placebo-controlled study to assess the efficacy & safety of tradipitant in reducing chronic pruritus (itching) in adults with atopic dermatitis (eczema). All enrolled subjects will receive oral medication to be taken twice daily for 8 weeks. There are 6 office visits throughout the study which ...

Phase

This is a 52-week, randomized double-blind, placebo- and active comparator-controlled study for adults with stable moderate to severe plaque psoriasis. This study is testing the efficacy, safety, and durability response of BMS-986165 versus placebo and a currently available treatment for psoriasis. There are 18 office visits throughout the study and ...

Phase

This is a double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of Tralokinumab for the treatment of moderate to severe Atopic Dermatitis. All enrolled participants will receive subcutaneous injections of medication every two weeks for 52 weeks. There are 16 in-office visits throughout the study and ...

Phase

This is a multicenter double-blind, randomized, placebo-controlled study to assess the efficacy and safety of IDP-124 lotion for the treatment of moderate to severe atopic dermatitis (eczema). All enrolled subjects will receive a lotion medication to be applied twice daily for 6 weeks. There are 7 office visits throughout the ...

Phase

This is a 24-week, randomized double-blind study for adults with moderate-to-severe plaque psoriasis. This study is comparing the efficacy and safety of ixekizumab to guselkumab. There are 15 office visits throughout the study and can include a physical exam, urine sampling, ECGs, blood draws, and assessments by qualified professionals and ...

Phase